V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280010190 | 280005470 | 1.83 | 14.7 | Palliative (P) | null | 2017-04-17 | DOXORUBICIN | N | N | 280026905 | DOXORUBICIN |
| 280010191 | 280005473 | 1.72 | 21.9 | Curative (C) | 2016-03-28 | 2016-03-28 | CARBOPLATIN + RT | N | Y | 280026919 | CARBOPLATIN + RT |
| 280010192 | 280005475 | 1.61 | 55.1 | Palliative (P) | 2015-04-27 | 2016-01-18 | Paclitaxel 80mg/m2 day 1 8 15 | Y | N | 280026921 | PACLITAXEL |
| 280010193 | 280008882 | 1.78 | 80 | Adjuvant (A) | null | 2015-03-11 | CARBOPLATIN + RT | N | Y | 280026927 | CARBOPLATIN + RT |
| 280010194 | 280005477 | 1.6 | null | Adjuvant (A) | 2014-04-27 | 2014-06-21 | Cisplatin | N | null | 280026932 | CISPLATIN |
| 280010195 | 280005481 | 1.7 | 72 | Palliative (P) | 2013-04-06 | 2013-05-02 | STS Rhabdomyosarcoma RMS 2005 IVA | Y | Y | 280026935 | IVA |
| 280010196 | 280008885 | 1.76 | null | Curative (C) | 2016-08-31 | 2016-09-16 | CARBOPLATIN + RT | N | Y | 280026948 | CARBOPLATIN + RT |
| 280010197 | 280005486 | 1.71 | 64 | Palliative (P) | 2013-07-31 | 2013-09-10 | STS Rhabdomyosarcoma RMS 2005 IVA | null | null | 280026961 | IVA |
| 280010198 | 280008886 | 1.63 | 67 | Palliative (P) | null | 2016-06-28 | Paclitaxel 7 day | 02 | N | 280026967 | PACLITAXEL |
| 280010199 | 280005487 | 1.79 | 96 | Palliative (P) | 2013-03-07 | 2013-04-24 | Doxorubin 50mg/m2 | N | N | 280026973 | DOXORUBICIN |
| 280010200 | 280005489 | 1.75 | 61.9 | Palliative (P) | 2014-11-20 | 2014-11-21 | DOXORUBICIN | null | null | 280026978 | DOXORUBICIN |
| 280010201 | 280005489 | null | 57.8 | Not known (9) | 2017-11-10 | 2018-01-27 | Cisplatin 7 day | 02 | null | 280026978 | CISPLATIN |
| 280010202 | 280005491 | 1.73 | 72.6 | Palliative (P) | 2018-11-05 | 2018-12-17 | Ifosfamide PVI 1g/m2 14day | 02 | N | 280026991 | IFOSFAMIDE |
| 280010203 | 280005493 | 1.69 | 16.5 | Palliative (P) | 2017-03-07 | 2017-09-05 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 280026997 | RMS 2005 TRIAL |
| 280010204 | 280005494 | null | 75.75 | Disease modification (D) | 2016-03-29 | 2016-06-25 | STS Rhabdomyosarcoma RMS 2005 IVADo | 02 | N | 280027001 | RMS 2005 TRIAL |
| 280010205 | 280005495 | 1.58 | 70.1 | Palliative (P) | 2017-01-27 | 2017-10-08 | STS Rhabdo RMS 2005 Vin Cyclo | Y | null | 280027004 | RMS 2005 TRIAL |
| 280010206 | 280008896 | 1.53 | 106.8 | Palliative (P) | 2017-02-20 | 2018-09-28 | STS Rhabdomyosarcoma RMS 2005 IVADo | 02 | N | 280027045 | RMS 2005 TRIAL |
| 280010207 | 280005505 | null | 55.1 | Palliative (P) | 2013-12-16 | 2014-02-10 | CETUXIMAB + RT | Y | N | 280027046 | CETUXIMAB + RT |
| 280010208 | 280005507 | null | 65.5 | Curative (C) | 2018-02-08 | 2018-02-13 | CARBOPLATIN + RT | 02 | Y | 280027050 | CARBOPLATIN + RT |
| 280010209 | 280005507 | 1.88 | 64.8 | Palliative (P) | 2017-07-24 | 2017-07-29 | DOXORUBICIN | 02 | N | 280027050 | DOXORUBICIN |
| 280010210 | 280005510 | 1.56 | 63.9 | Palliative (P) | 2016-09-12 | 2016-09-13 | Paclitaxel 80mg/m2 day 1 8 15 | N | null | 280027084 | PACLITAXEL |
| 280010211 | 280005512 | 0 | 67 | null | 2015-09-23 | 2015-10-20 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 280027091 | IVA |
| 280010212 | 280005512 | 1.85 | null | Palliative (P) | null | 2014-05-27 | DOXORUBICIN | 02 | N | 280027091 | DOXORUBICIN |
| 280010213 | 280005519 | null | 68.3 | Palliative (P) | 2017-05-30 | 2017-06-10 | Doxorubicin 20mg/m2 7 day | N | N | 280027121 | DOXORUBICIN |
| 280010214 | 280005521 | 1.61 | 68 | Curative (C) | 2016-05-01 | 2016-10-07 | Cetuximab + Radiotherapy Maint | N | null | 280027123 | CETUXIMAB + RT |
| 280010215 | 280008902 | 1.65 | 16.8 | Palliative (P) | 2013-01-07 | 2013-02-25 | Ifosfamide | 02 | N | 280027126 | IFOSFAMIDE |
| 280010216 | 280011718 | 1.79 | null | Palliative (P) | 2017-03-09 | 2017-03-21 | PACLITAXEL | 02 | N | 280027134 | PACLITAXEL |
| 280010217 | 280005528 | 1.75 | 117.9 | null | null | 2016-10-17 | PACLITAXEL | N | N | 280027162 | PACLITAXEL |
| 280010218 | 280005532 | 1.72 | null | Neo-adjuvant (N) | 2015-12-10 | 2016-03-13 | Doxorubicin 75mg/m2 | N | N | 280027178 | DOXORUBICIN |
| 280010219 | 280005534 | 1.84 | 82.6 | Neo-adjuvant (N) | 2013-12-18 | 2014-01-07 | DOXORUBICIN | N | N | 280027179 | DOXORUBICIN |
| 280010220 | 280005536 | 1.71 | 10.55 | null | 2016-09-17 | 2018-01-04 | Ifosfamide PVI 1g/m2 14day | N | N | 280027182 | IFOSFAMIDE |
| 280010221 | 280005542 | 1.58 | null | Palliative (P) | 2015-11-05 | 2015-11-29 | Cetuximab + Radiotherapy Maint | N | Y | 280027206 | CETUXIMAB + RT |
| 280010222 | 280005546 | 1.73 | 62 | Palliative (P) | 2013-05-18 | 2013-06-02 | PACLITAXEL | N | N | 280027219 | PACLITAXEL |
| 280010223 | 280005547 | 1.48 | 62.1 | Palliative (P) | 2016-10-31 | 2017-05-09 | Ifosfamide PVI 1g/m2 14day | 02 | N | 280027222 | IFOSFAMIDE |
| 280010224 | 280005548 | 1.82 | 81 | Palliative (P) | null | 2017-12-21 | CETUXIMAB + RT | null | null | 280027236 | CETUXIMAB + RT |
| 280010225 | 280008915 | 1.76 | 69.8 | Palliative (P) | null | 2013-12-12 | Cisplatin | 02 | N | 280027268 | CISPLATIN |
| 280010226 | 280005555 | 1.8 | 57.2 | Palliative (P) | 2016-08-09 | 2016-11-03 | Cisplatin | N | N | 280027285 | CISPLATIN |
| 280010227 | 280005558 | null | 72 | Palliative (P) | 2018-02-07 | 2018-05-12 | STS Rhabdomyosarcoma RMS 2005 IVA | Y | N | 280027305 | IVA |
| 280010228 | 280005558 | null | null | null | 2013-02-25 | 2013-10-07 | Cetuximab + Radiotherapy Maint | 02 | N | 280027305 | CETUXIMAB + RT |
| 280010229 | 280005561 | 1.72 | 86.8 | Palliative (P) | 2013-12-12 | 2013-12-15 | Cisplatin 7 day | 02 | N | 280027321 | CISPLATIN |
| 280010230 | 280005562 | 1.59 | null | Adjuvant (A) | 2016-06-03 | 2016-04-18 | CARBOPLATIN + RT | N | N | 280027329 | CARBOPLATIN + RT |
| 280010231 | 280005562 | null | 59.9 | Neo-adjuvant (N) | 2017-08-14 | 2017-08-14 | DOXORUBICIN | 02 | null | 280027329 | DOXORUBICIN |
| 280010232 | 280005565 | 1.69 | 78.2 | Palliative (P) | 2018-02-16 | 2018-03-09 | Cetuximab + Radiotherapy Load | N | N | 280027352 | CETUXIMAB + RT |
| 280010233 | 280005568 | 1.6 | 17.5 | Palliative (P) | 2015-01-26 | 2015-02-22 | CETUXIMAB + RT | N | null | 280027353 | CETUXIMAB + RT |
| 280010234 | 280005569 | 1.79 | 80.2 | Palliative (P) | 2015-04-23 | 2015-08-09 | Doxorubicin 75mg/m2 | N | N | 280027360 | DOXORUBICIN |
| 280010235 | 280005572 | 1.62 | 54.3 | Palliative (P) | 2015-02-01 | 2015-04-13 | CETUXIMAB + RT | null | null | 280027379 | CETUXIMAB + RT |
| 280010237 | 280005574 | 1.74 | 98 | Palliative (P) | 2015-08-23 | 2015-09-06 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | 280027391 | PACLITAXEL |
| 280010238 | 280005576 | 1.72 | 14 | Adjuvant (A) | 2017-07-21 | 2017-07-21 | CARBOPLATIN + RT | N | Y | 280027394 | CARBOPLATIN + RT |
| 280010239 | 280005577 | 1.7 | 68.2 | Palliative (P) | null | 2014-12-17 | CETUXIMAB + RT | N | N | 280027395 | CETUXIMAB + RT |
| 280010240 | 280005579 | 1.7 | 85 | null | 2015-10-14 | 2015-10-14 | IVA | N | N | 280027402 | IVA |